Skip to main content
. Author manuscript; available in PMC: 2009 Jul 6.
Published in final edited form as: Expert Opin Emerg Drugs. 2009 Jun;14(2):207–217. doi: 10.1517/14728210902946399

Table 1.

Summary of medical need.

Infants aged 2 – 8 months
during the RSV season
Passive
immunoprophylaxis;
possibly vaccines, if
immunogenic and safe
RSV-infected infants in
hospital or at home
Anti-viral drugs to limit
spread and perhaps
reduce disease severity
Care-givers of high-risk
children
Conventional vaccines
Elderly persons Vaccines and perhaps
anti-viral drugs

RSV: Respiratory syncytial virus.

HHS Vulnerability Disclosure